Biocon's fundraising is viewed positively to manage debt. Expert Nischal Maheshwari is optimistic about Biocon's future, expecting earlier investments to yield returns. He also favors contract development and manufacturing firms like Laurus Labs. Maheshwari sees potential in banking, metals, and power sectors, particularly execution-focused players in power.
